NPTX2

NPTX2 Produktliste

  • Attribut

    Protein (1)

  • Produktbibliothek

    Online (1)

  • Spezies

    Human (1)

  • Etikett

    His Tag (1)

  • Marker

    Unconjugated (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
Human
HEK293
Human NPTX2 Protein, His Tag (MALS verified)
In den Warenkorb legen
Gesamtmenge1
  • 1

NPTX2 Molekülhintergrund

Neuronal Pentraxin 2 (NPTX2), also named neuronal activity-regulated pentraxin, is a secreted glycoprotein characterized by a cyclic multimeric structure. In vivo, NTPX2 exerts various neurological effects by combining with the transmembrane protein neuronal pen traxin receptor (NPTXR). NPTX2 was thought to play a vital role in transmitting neurotrans mitters and maintaining synaptic plasticity. It also plays a role in clustering of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors at established synapses, resulting in non-apoptotic cell death of dopaminergic nerve cells. Up-regulation of this gene in Parkinson disease (PD) tissues suggests that the protein may be involved in the pathology of PD.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Paclitaxel/Hyaluronic acidPhase 3 ClinicalFidia PharmaCarcinoma, Papillary; Urinary Bladder Neoplasms
Details
Hydrogen peroxide/Hyaluronic acidBMG-0703Phase 3 ClinicalUniversity Of MilanPeriodontal Pocket; Bruxism; Gingival Hemorrhage; Gingivitis; Surgical Wound; Periodontitis
Details
CA-102NCA-102NPhase 2 ClinicalBiobudSolid tumours; Colorectal Neoplasms
Details
Multiple 4SCAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteBreast Neoplasms
Details
AMT-116(Multitude Therapeutics)AMT-116; AMT-116-ADCPhase 2 ClinicalMultitude Therapeutics IncSolid tumours; Head and Neck Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
CD44v6-specific CAR gene-engineered T cell therapy (Shenzhen Geno-Immune Medical Institute)4SCAR-CD44v6Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
Details
Hyaluronic acid/FluorouracilHA-5FU; HA-5-fluorouracil; Hyaluronic acid-5-fluorouracil complex; Hyaluronan acid-5-fluorouracil complexPhase 2 ClinicalMonash University, Alchemia LtdColorectal Neoplasms
Details
AMC-303AMC-303; HP-558Phase 1 ClinicalAmcure GmbhSolid tumours; Esophageal Squamous Cell Carcinoma
Details
Clodronic acid/Hyaluronic acidPhase 1 ClinicalAbiogen Pharma SpaOsteoarthritis
Details
YN-001YN001; YN-001Phase 1 ClinicalBeijing Inno Medicine Co LtdPlaque, Atherosclerotic; Atherosclerosis; Cerebrovascular Disorders; Cardiovascular Diseases
Details
BGC-0228BGC-0228Phase 1 ClinicalSolid tumours
Details
Hyaluronic acid inhalation (Actelion Pharmaceuticals)ETX-100; CTX-100Actelion Pharmaceuticals Ltd
Details
  • Produktliste
  • Klinische Arzneimittelinformation